Free Newsletter

  Email address:
   

Site Search

Oculus Announces SFDA Approval of Microcyn

publication date: Mar 31, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Oculus Innovative Sciences has received an approval from the SFDA of its Microcyn® Technology for treatment of several acute and chronic wounds including ulcers, cuts, contusions and burns. Microcyn is a super-oxygenated form of water that is not toxic, but highly effective against bacteria, viruses, mold and spores. Microcyn combines its anti-infective properties with the ability to promote wound healing. More details...

Stock Symbol: (NSDQ: OCLS)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio Events

October 24, 2008
Beijing, China

>> More details...

Partner Events
 
October 11-13, 2008
Dalian, China
 
November 08, 2008
The Institute of Americas, UCSDa
 
November 9-11, 2008
Shanghai, China
 
February 23-25, 2009
San Diego

>> More details...

Partners